In vitro diagnostics (IVD) concessions to France may usher in tougher controls
This article was originally published in Clinica
Executive Summary
The in vitro diagnostics industry in Europe faces stricter manufacturing controls for high-risk products and more powerful regulatory authorities than previously envisaged.